Give It a Shot Puts Male Birth Control in Focus

Give It a Shot arrives at a moment when the future of male birth control is attracting renewed attention. The documentary, directed by Vaishali Sinha, follows scientists and advocates working toward a reversible contraceptive option for men.

The film centers on Indian scientist Dr. Sujoy Guha and teams working in India and the United States. Their efforts are tied to a larger scientific question: can men have a reliable, reversible contraceptive option beyond condoms and vasectomy?

The documentary is scheduled for a limited U.S. theatrical release beginning September 4, 2026. It runs for approximately 92 minutes. RRotten Tomatoes+1

Rather than treating contraception as an issue that belongs primarily to women, Give It a Shot examines what could happen if responsibility for preventing pregnancy were shared more broadly.

Give It a Shot Examines a Long-Running Scientific Quest

At the heart of Give It a Shot is the work of Dr. Sujoy Guha, whose research into male contraception dates back decades.

Guha developed the concept behind RISUG, short for Reversible Inhibition of Sperm Under Guidance. The approach involves placing a polymer into the vas deferens, the ducts that carry sperm.

Research literature describes RISUG as a non-hormonal, intravasal contraceptive approach. The polymer is designed to interfere with sperm as they pass through the reproductive tract. PPubMed Central (PMC)+1

The idea is significant because conventional male contraception has remained comparatively limited.

Condoms are widely available and provide protection against sexually transmitted infections as well as pregnancy. Vasectomy, meanwhile, is considered a permanent contraceptive method, even though fertility restoration can sometimes be attempted.

A reversible method would occupy a different space.

It could potentially allow men to take responsibility for contraception for a period of time and later seek restoration of fertility.

Why Reversible Male Contraception Matters

The appeal of a reversible male contraceptive is straightforward.

Pregnancy prevention is often a shared responsibility between partners, yet contraceptive choices have historically been distributed unevenly between men and women.

Women have access to a wide range of options, including pills, implants, intrauterine devices, injections, patches and rings. Men have far fewer established choices.

The Guttmacher Institute’s current U.S. contraception information lists numerous female-controlled and coital methods, while male options include condoms and vasectomy among established approaches. GGuttmacher Institute+1

That imbalance is one of the central issues raised by the story behind Give It a Shot.

A successful reversible male contraceptive could give couples another tool when deciding how to prevent pregnancy. It could also reduce the extent to which women alone carry the physical and medical burden associated with contraception.

However, scientific promise does not automatically translate into an approved consumer product.

RISUG Has Been Studied for Decades

RISUG is not a brand-new scientific idea.

Academic literature traces its development to research by Guha beginning in the 1970s. Early experiments investigated the possibility of using a polymer to interfere with sperm inside the vas deferens. SSpringer+1

Over time, researchers conducted laboratory and animal studies before moving toward human clinical research.

One published clinical study involved 139 men who received an intravasal RISUG injection. Researchers followed participants for health and semen-related outcomes, as well as pregnancy outcomes involving their partners. PPubMed+1

The published results reported temporary scrotal enlargement and mild scrotal or inguinal pain among participants, with those symptoms resolving within about a month. The researchers reported no pregnancies during the six-month follow-up period. PPubMed Central (PMC)

Those findings are important, but they should not be interpreted as proof that RISUG is already an approved, widely available contraceptive.

The distinction between promising clinical research and regulatory approval remains critical.

The Biggest Question Is Reversibility

The word “reversible” is perhaps the most important part of the RISUG concept.

For a contraceptive to be genuinely reversible, researchers need strong evidence that fertility can return after the contraceptive effect is stopped or removed.

This is where the scientific record becomes more complicated.

Reviews of male contraception research have reported evidence of reversibility in animal models, including studies involving rodents and non-human primates. But researchers have also emphasized the need for human evidence demonstrating reliable recovery of fertility. PPubMed Central (PMC)+1

That distinction matters because temporary contraception and reversible contraception are not necessarily synonymous.

A method can suppress fertility for an extended period without yet having enough evidence to guarantee that fertility will reliably return after treatment.

For potential users, that is a major consideration.

For regulators and developers, it is an even bigger one.

Give It a Shot Connects Science With Social Questions

The documentary’s subject is scientific, but the implications extend beyond laboratories and clinical trials.

Give It a Shot asks why male contraception has remained so limited despite decades of research.

That question involves more than chemistry and reproductive biology.

It also raises issues surrounding pharmaceutical investment, regulatory requirements, social expectations and the willingness of men to adopt new contraceptive methods.

The film’s official materials describe the story as a global effort involving scientists and developers in India and the United States. They also frame male contraception as an issue with potential implications for gender equity and family planning. GGive It A Shot Film

Those questions make the documentary relevant beyond audiences already interested in reproductive science.

It is also a story about how medical innovation moves—or fails to move—from the laboratory into everyday life.

A New Male Contraceptive Could Change Family Planning

If a safe and reversible male contraceptive eventually reaches the market, its effects could extend beyond individual couples.

For example, couples could have another option when existing methods are unsuitable because of side effects, personal preferences, medical considerations or lifestyle factors.

A male-controlled method could also change conversations about responsibility.

Instead of contraception being treated primarily as something women manage, couples could have more opportunities to divide that responsibility according to their own circumstances.

There would still be important questions.

Would men use it? Would doctors recommend it? How would regulators evaluate long-term safety? How quickly would pharmaceutical companies invest in manufacturing and distribution?

Those questions cannot be answered simply by demonstrating that a contraceptive works in clinical research.

Why the Documentary Arrives at an Interesting Time

The timing of Give It a Shot is notable because male contraception remains an active area of scientific research.

Researchers continue to investigate hormonal and non-hormonal approaches. These include methods designed to suppress sperm production as well as approaches intended to prevent sperm from reaching or fertilizing an egg.

RISUG belongs to the latter group of approaches because it is designed to act within the vas deferens rather than relying on systemic hormonal suppression.

Scientific reviews have identified both potential advantages and unresolved questions surrounding such methods. PPubMed Central (PMC)+1

The documentary therefore arrives with a story that has already been developing for decades.

Its central characters are not beginning from scratch. They are part of a much longer effort to expand contraceptive choices for men.

Give It a Shot Is More Than a Medical Story

The strongest reason to pay attention to Give It a Shot may be that its subject is easy to understand.

Most people understand the basic purpose of contraception.

What is less familiar is the long scientific history behind attempts to create a reversible male contraceptive.

That makes the documentary an opportunity to examine the gap between an intriguing scientific idea and a product that ordinary people can actually use.

The film’s official description calls the story funny, moving and urgent. Its festival history includes screenings at documentary and South Asian film festivals, while the filmmakers say the project has received recognition including a jury award at the Indie Meme Film Festival. GGive It A Shot Film

Those developments suggest that the film is being positioned not simply as a medical documentary but as a broader social conversation.

What Viewers Should Know Before Watching

Anyone approaching Give It a Shot should separate three different questions.

First, is the science interesting? Clearly, the research behind RISUG represents an unusual and longstanding attempt to develop another form of male contraception.

Second, does the research establish a potential contraceptive effect? Published clinical studies provide evidence that the approach has been investigated in humans and can produce substantial sperm suppression. PPubMed+1

Third, is there already a universally available, fully approved reversible male contraceptive based on RISUG? That is a different question, and the available research should not be presented as equivalent to widespread regulatory approval.

This distinction is particularly important as documentaries and news coverage bring emerging medical technologies to a larger audience.

The Bigger Conversation About Contraception

Ultimately, Give It a Shot points toward a broader debate about who should carry responsibility for preventing unintended pregnancy.

For decades, contraceptive development has produced a much larger range of established options for women than for men.

The consequences are practical as well as social.

Women may experience side effects from hormonal contraception or undergo procedures that require medical intervention. Men, by comparison, have traditionally had fewer established options.

A successful reversible male contraceptive would not eliminate those existing choices.

Instead, it could add another option.

That could give couples greater flexibility and potentially make contraception a more genuinely shared decision.

Final Verdict: A Timely Film About an Unfinished Revolution

Give It a Shot focuses on an ambitious scientific goal: creating a reliable male contraceptive that can prevent pregnancy without permanently eliminating fertility.

Its story stretches from decades of research by Dr. Sujoy Guha to contemporary efforts involving scientists and advocates in India and the United States.

The science is promising enough to warrant attention, but important questions remain—especially around long-term safety, regulatory approval and demonstrated reversibility in humans. PPubMed+1

That uncertainty is part of what makes the story compelling.

The development of male birth control is not simply a race to invent another medical product. It is also a test of whether reproductive responsibility can become more evenly distributed.

With its theatrical release beginning September 4, Give It a Shot brings that unfinished scientific and social debate to a wider audience. GGive It A Shot Film

For viewers interested in reproductive health, medical innovation or the future of family planning, the documentary offers a timely reason to look more closely at a field that has spent decades searching for its next breakthrough.

Suggested External Sources

• Official Give It a Shot film website
• Guttmacher Institute contraception research
• PubMed clinical research on RISUG
• Springer review of RISUG research

Suggested Internal Link

[YOUR WEBSITE]: Add an internal link to your existing article about male contraception, family planning, reproductive health, or new medical technology.

Image

Recommended image: Official Give It a Shot film poster or authorized promotional still.

Image ALT Text:
Give It a Shot male birth control documentary

Image caption:
Give It a Shot examines the decades-long effort to develop reversible male contraception.

A note on SEO: no system can truthfully guarantee that Yoast or RankMath will be green without seeing your site’s actual settings, internal-link structure, permalink configuration and plugin version. The draft above is structured to target those requirements, but the final indicators should be checked inside WordPress.

Also, because the NYT page itself was inaccessible, I deliberately did not attribute any specific opinions or wording to the NYT reviewer. The article above is an original report based on independently accessible sources